Transition from parental prostacyclin to selexipag: a case series of five pulmonary arterial hypertension patients
Author:
Affiliation:
1. Cardiovascular DivisionUniversity of Minnesota Medical SchoolMinneapolisMNUSA
Funder
National Institutes of Health
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894019862167
Reference4 articles.
1. World Health Organization Group I Pulmonary Hypertension
2. Pulmonary arterial hypertension: pathogenesis and clinical management
3. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
4. Selexipag for the Treatment of Pulmonary Arterial Hypertension
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pulmonary Assessment of the Liver Transplant Recipient;Journal of Clinical and Experimental Hepatology;2023-09
2. Management of Pulmonary Arterial Hypertension;Seminars in Respiratory and Critical Care Medicine;2023-06-27
3. Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report;ESC Heart Failure;2023-06-19
4. Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension;Pulmonary Circulation;2022-10
5. Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension;Expert Opinion on Drug Safety;2022-04-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3